Ting Zhou Ming Yuan Pengfei Cui Jingjing Li Feifei Jia Shixuan Wang Ronghua Liu
10.3389/fmed.2022.888186
Front Med (Lausanne)
2022 Aug 3;9:888186.
anaerobes levofloxacin morinidazole pelvic inflammatory disease safety
CC BY
https://pubmed.ncbi.nlm.nih.gov/35991648/
Case Reports
PMC9382104
35991648
Effectiveness and safety of morinidazole in the treatment of pelvic inflammatory disease: A multicenter, prospective, open-label phase IV trial
2022